Back
Arcutis Biotherapeutics Stock Price Chart
Trump's Tariffs Are Reshaping Markets
Grade any 3 stocks FREE to see if your portfolio is at risk.
Buy
66
ARQT
Arcutis Biotherapeutics
Last Price:
$14.37
Seasonality Move:
2.78%
7 Day Trial
ALL ACCESS PASS
$
7
The EXACT DAY Certain Stocks Soar - Year After Year
Find out now - completely free of charge.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ARQT is experiencing buying pressure, which is a positive indicator for future bullish movement.
Arcutis Biotherapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 13.52 | Buy |
| 20-day SMA: | 13.8 | Buy |
| 50-day SMA: | 14.17 | Buy |
| 200-day SMA: | 12.44 | Buy |
| 8-day EMA: | 13.69 | Buy |
| 20-day EMA: | 13.81 | Buy |
| 50-day EMA: | 14.02 | Buy |
| 200-day EMA: | 12.71 | Buy |
Arcutis Biotherapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.16 | Sell |
| Relative Strength Index (14 RSI): | 54.79 | Buy |
| Chaikin Money Flow: | 1464947 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (13.35 - 14.51) | Buy |
| Bollinger Bands (100): | (12.82 - 15.28) | Buy |
Arcutis Biotherapeutics Technical Analysis
| May 23 | May 27 | May 28 | May 29 | May 30 | Jun 2 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | Jun | |||||||||
| 23 | 27 | 28 | 29 | 30 | 02 | 03 | 04 | 05 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Arcutis Biotherapeutics Stock
Is Arcutis Biotherapeutics Stock a Buy?
-
Arcutis Biotherapeutics share price is 14.37 while ARQT 8-day simple moving average is 13.52, which is a Buy signal.
-
The stock price of ARQT is 14.37 while Arcutis Biotherapeutics 20-day SMA is 13.80, which makes it a Buy.
-
Arcutis Biotherapeutics 50-day simple moving average is 14.17 while ARQT share price is 14.37, making it a Buy technically.
-
ARQT stock price is 14.37 and Arcutis Biotherapeutics 200-day simple moving average is 12.44, creating a Buy signal.
ARQT Technical Analysis vs Fundamental Analysis
Buy
66
Arcutis Biotherapeutics (ARQT)
is a Buy
Is Arcutis Biotherapeutics a Buy or a Sell?
-
Arcutis Biotherapeutics stock is rated a BuyThe current Arcutis Biotherapeutics [ARQT] share price is $14.37. The Score for ARQT is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
Arcutis Biotherapeutics Stock Info
Market Cap:
1.7B
Price in USD:
14.37
Share Volume:
2.4M
Arcutis Biotherapeutics 52-Week Range
52-Week High:
17.75
52-Week Low:
6.99
Buy
66
Arcutis Biotherapeutics (ARQT)
is a Buy
Arcutis Biotherapeutics Share Price Forecast
-
What is the Arcutis Biotherapeutics stock price today?The Arcutis Biotherapeutics stock price is 14.37 USD today.
-
Will ARQT stock go up or go down?Arcutis Biotherapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Arcutis Biotherapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Arcutis Biotherapeutics is not overvalued.
Is Arcutis Biotherapeutics Stock a Buy?
-
Arcutis Biotherapeutics share price is 14.37 while ARQT 8-day exponential moving average is 13.69, which is a Buy signal.
-
The stock price of ARQT is 14.37 while Arcutis Biotherapeutics 20-day EMA is 13.81, which makes it a Buy.
-
Arcutis Biotherapeutics 50-day exponential moving average is 14.02 while ARQT share price is 14.37, making it a Buy technically.
-
ARQT stock price is 14.37 and Arcutis Biotherapeutics 200-day simple moving average is 12.71, creating a Buy signal.
Fundamental Analysis of Arcutis Biotherapeutics
Is Arcutis Biotherapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.30 per share, an increase next quarter of $0.17 per share, an increase this year of $0.79 per share, and an increase next year of $0.72 per share.
Technical Analysis of Arcutis Biotherapeutics
Should I short Arcutis Biotherapeutics stock?
-
ARQT Moving Average Covergence Divergence (MACD) indicator is -0.16, suggesting Arcutis Biotherapeutics is a Sell
-
Arcutis Biotherapeutics Relative Strength Index (RSI) is 54.79, which suggest Arcutis Biotherapeutics is overbought
-
The Bollinger Bands (25) for Arcutis Biotherapeutics is (13.35 - 14.51), which suggest Arcutis Biotherapeutics is a Buy
-
The Bollinger Bands (100) for Arcutis Biotherapeutics is (12.82 - 15.28), which suggest Arcutis Biotherapeutics is a Buy
* Arcutis Biotherapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.